Aquestive Therapeutics, Inc.
AQST· Nasdaq
AQSTAquestive Therapeutics, Inc.
Filed Aug 6, 2019 · 10-Q · 37 days after period end · 0001140361-19-014361
| Metric | Q2 2019 | Q2 2018 | Q2 2017 |
|---|---|---|---|
| Revenue | $11.13M | $13.93M | $11.14M |
| Net Income | -$20.47M | -$36.49M | -$5.90M |
| EPS Diluted | -$0.82 | -$1.90 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Aquestive Therapeutics, Inc. · CIK 1398733 · Engraved from SEC EDGAR
ended Jun 30, 2019 · filed Aug 6, 2019 · 37 d after period end
